AF-219
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AF-219, covering 2017-01-12 to 2020-10-22. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010) [Phase 2]